Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

‘Prostate cancer and the ProtecT study – The story…’

Prof Freddie Hamdy© Academy of Medical SciencesProfessor Freddie Hamdy is Head of Department at the Nuffield Department of Surgical Sciences, and the Chief Investigator of The ProtecT Trial - the first trial to evaluate the effectiveness, cost-effectiveness and acceptability of three major treatment options: active monitoring, surgery (radical prostatectomy) and radiotherapy for men with localised prostate cancer.  

In September 2016, Professor Hamdy and his team published the first results of their 10 year study and made international headlines. A trial of 1,643 men with small prostate cancers resulted in the same 99% survival rate after a decade for those who had had surgery, radiotherapy or simply monitored the tumour. 


All members of the University and NHS clinical staff are welcome.